Cargando…

The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial

BACKGROUND: Accurate risk stratification in pulmonary arterial hypertension (PAH), a devastating cardiopulmonary disease, is essential to guide successful therapy. Machine learning may improve risk management and harness clinical variability in PAH. METHODS: We conducted a long-term retrospective ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Sonnweber, Thomas, Tymoszuk, Piotr, Steringer-Mascherbauer, Regina, Sigmund, Elisabeth, Porod-Schneiderbauer, Stephanie, Kohlbacher, Lisa, Theurl, Igor, Lang, Irene, Weiss, Günter, Löffler-Ragg, Judith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131314/
https://www.ncbi.nlm.nih.gov/pubmed/37098543
http://dx.doi.org/10.1186/s12890-023-02427-2
_version_ 1785031150899560448
author Sonnweber, Thomas
Tymoszuk, Piotr
Steringer-Mascherbauer, Regina
Sigmund, Elisabeth
Porod-Schneiderbauer, Stephanie
Kohlbacher, Lisa
Theurl, Igor
Lang, Irene
Weiss, Günter
Löffler-Ragg, Judith
author_facet Sonnweber, Thomas
Tymoszuk, Piotr
Steringer-Mascherbauer, Regina
Sigmund, Elisabeth
Porod-Schneiderbauer, Stephanie
Kohlbacher, Lisa
Theurl, Igor
Lang, Irene
Weiss, Günter
Löffler-Ragg, Judith
author_sort Sonnweber, Thomas
collection PubMed
description BACKGROUND: Accurate risk stratification in pulmonary arterial hypertension (PAH), a devastating cardiopulmonary disease, is essential to guide successful therapy. Machine learning may improve risk management and harness clinical variability in PAH. METHODS: We conducted a long-term retrospective observational study (median follow-up: 67 months) including 183 PAH patients from three Austrian PAH expert centers. Clinical, cardiopulmonary function, laboratory, imaging, and hemodynamic parameters were assessed. Cox proportional hazard Elastic Net and partitioning around medoid clustering were applied to establish a multi-parameter PAH mortality risk signature and investigate PAH phenotypes. RESULTS: Seven parameters identified by Elastic Net modeling, namely age, six-minute walking distance, red blood cell distribution width, cardiac index, pulmonary vascular resistance, N-terminal pro-brain natriuretic peptide and right atrial area, constituted a highly predictive mortality risk signature (training cohort: concordance index = 0.82 [95%CI: 0.75 – 0.89], test cohort: 0.77 [0.66 – 0.88]). The Elastic Net signature demonstrated superior prognostic accuracy as compared with five established risk scores. The signature factors defined two clusters of PAH patients with distinct risk profiles. The high-risk/poor prognosis cluster was characterized by advanced age at diagnosis, poor cardiac output, increased red cell distribution width, higher pulmonary vascular resistance, and a poor six-minute walking test performance. CONCLUSION: Supervised and unsupervised learning algorithms such as Elastic Net regression and medoid clustering are powerful tools for automated mortality risk prediction and clinical phenotyping in PAH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-023-02427-2.
format Online
Article
Text
id pubmed-10131314
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101313142023-04-27 The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial Sonnweber, Thomas Tymoszuk, Piotr Steringer-Mascherbauer, Regina Sigmund, Elisabeth Porod-Schneiderbauer, Stephanie Kohlbacher, Lisa Theurl, Igor Lang, Irene Weiss, Günter Löffler-Ragg, Judith BMC Pulm Med Research Article BACKGROUND: Accurate risk stratification in pulmonary arterial hypertension (PAH), a devastating cardiopulmonary disease, is essential to guide successful therapy. Machine learning may improve risk management and harness clinical variability in PAH. METHODS: We conducted a long-term retrospective observational study (median follow-up: 67 months) including 183 PAH patients from three Austrian PAH expert centers. Clinical, cardiopulmonary function, laboratory, imaging, and hemodynamic parameters were assessed. Cox proportional hazard Elastic Net and partitioning around medoid clustering were applied to establish a multi-parameter PAH mortality risk signature and investigate PAH phenotypes. RESULTS: Seven parameters identified by Elastic Net modeling, namely age, six-minute walking distance, red blood cell distribution width, cardiac index, pulmonary vascular resistance, N-terminal pro-brain natriuretic peptide and right atrial area, constituted a highly predictive mortality risk signature (training cohort: concordance index = 0.82 [95%CI: 0.75 – 0.89], test cohort: 0.77 [0.66 – 0.88]). The Elastic Net signature demonstrated superior prognostic accuracy as compared with five established risk scores. The signature factors defined two clusters of PAH patients with distinct risk profiles. The high-risk/poor prognosis cluster was characterized by advanced age at diagnosis, poor cardiac output, increased red cell distribution width, higher pulmonary vascular resistance, and a poor six-minute walking test performance. CONCLUSION: Supervised and unsupervised learning algorithms such as Elastic Net regression and medoid clustering are powerful tools for automated mortality risk prediction and clinical phenotyping in PAH. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12890-023-02427-2. BioMed Central 2023-04-25 /pmc/articles/PMC10131314/ /pubmed/37098543 http://dx.doi.org/10.1186/s12890-023-02427-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Sonnweber, Thomas
Tymoszuk, Piotr
Steringer-Mascherbauer, Regina
Sigmund, Elisabeth
Porod-Schneiderbauer, Stephanie
Kohlbacher, Lisa
Theurl, Igor
Lang, Irene
Weiss, Günter
Löffler-Ragg, Judith
The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial
title The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial
title_full The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial
title_fullStr The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial
title_full_unstemmed The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial
title_short The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial
title_sort combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension—a long-term retrospective multicenter trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131314/
https://www.ncbi.nlm.nih.gov/pubmed/37098543
http://dx.doi.org/10.1186/s12890-023-02427-2
work_keys_str_mv AT sonnweberthomas thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT tymoszukpiotr thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT steringermascherbauerregina thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT sigmundelisabeth thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT porodschneiderbauerstephanie thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT kohlbacherlisa thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT theurligor thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT langirene thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT weissgunter thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT lofflerraggjudith thecombinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT sonnweberthomas combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT tymoszukpiotr combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT steringermascherbauerregina combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT sigmundelisabeth combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT porodschneiderbauerstephanie combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT kohlbacherlisa combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT theurligor combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT langirene combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT weissgunter combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial
AT lofflerraggjudith combinationofsupervisedandunsupervisedlearningbasedriskstratificationandphenotypinginpulmonaryarterialhypertensionalongtermretrospectivemulticentertrial